A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys

NCT01878786 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Interim results suggested a concern for patient outcomes and safety

Conditions

Delayed Graft Function

Interventions

DRUG: Everolimus
DRUG: Tacrolimus
DRUG: Mycophenolate mofetil (MMF/MPA)

Sponsor

Matthew Cooper